EUVIMEDEUVIMED entdecken
Crossref

Sodium R-lipoate protects against psoriatic skin inflammation via modulating IL-23/IL-17A axis, oxidative stress, and mast cell activation

Gehan Waheed, Hend A Mohammed, Gamal Ramadan

Naunyn-Schmiedeberg's Archives of Pharmacology · 2026

DOI: 10.1007/s00210-026-05431-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2026. Verfasst von Gehan Waheed und 2 weiteren Autor:innen. Beteiligte Einrichtung: Zoology Department, Faculty of Science, Ain Shams University, Khalifa El-Maamon st., Abbasiya sq, 11566, Cairo, Egypt. Hauptthemen laut MEDLINE: Mast Cells, Psoriasis, Anti-Inflammatory Agents. Die Arbeit nennt 63 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Psoriasis is a prevalent dermatological condition characterized by chronic inflammation, affecting an estimated 2-3% of the global population. Current therapies for psoriasis can relieve symptoms, but their serious adverse effects and financial burdens are significant. Hence, it is urgent to focus on natural product-originated agents to develop much safer, more effective, and low-cost treatments. Here, we determined and compared the efficacy of sodium R-lipoate (NaRLA, 50 and 100 mg/kg body weight/day), given orally for 8 consecutive days, in a BALB/c mouse model of imiquimod-induced psoriatic skin inflammation, in comparison with the synthetic drug methotrexate (MTX). Moreover, the vascular permeability (Evans blue) response was investigated. Our results revealed that NaRLA (especially at the high dose) exhibited better performance like MTX in alleviating (P < 0.05-0.001) the symptoms of psoriasis (erythema, scaling, and skin thickness), as well as the psoriasis area and severity index score, body weight loss, splenomegaly, the deteriorating histopathology, and oxidative stress. Most importantly, NaRLA decreased (P < 0.05-0.001) the elevated expression of interleukin (IL)-23 and IL-17A (key cytokines involved in psoriasis pathogenesis), markedly inhibited phosphorylation of nuclear factor-κBp65, and downregulated tumor necrosis factor-α, IL-1β, and cyclooxygenase-2 levels in mice skin tissues. Furthermore, NaRLA resulted in a significant improvement (P < 0.001) on both Evans blue extravasation and mast cell degranulation, suggesting a reduction in inflammation and edema. Thus, our observations imply that NaRLA may serve as an effective agent for alleviating psoriatic skin inflammation via targeting IL-23/IL-17A axis and mast cell degranulation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mast CellsPsoriasisAnti-Inflammatory AgentsAnimalsInterleukin-17Oxidative StressMice, Inbred BALB CMiceSkinImiquimodFemaleDisease Models, AnimalMaleInterleukin-23InflammationInterleukin-23 Subunit p19

Stichwörter der Autor:innen

IL-23/IL-17A axisMast cellsOxidative stressPhospho-NF-κBp65Plaque psoriasisSodium R-lipoate

Substanzen

Interleukin-17Anti-Inflammatory AgentsIl17a protein, mouseImiquimodInterleukin-23Il23a protein, mouseInterleukin-23 Subunit p19

Autor:innen und Institutionen

  • Zoology Department, Faculty of Science, Ain Shams University, Khalifa El-Maamon st., Abbasiya sq, 11566, Cairo, Egypt.
  • Zoology Department, Faculty of Science, Ain Shams University, Khalifa El-Maamon st., Abbasiya sq, 11566, Cairo, Egypt. gramadan@sci.asu.edu.eg.

Zitieren

APA

Waheed, G., Mohammed, H. A., & Ramadan, G. (2026). Sodium R-lipoate protects against psoriatic skin inflammation via modulating IL-23/IL-17A axis, oxidative stress, and mast cell activation. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-026-05431-5

Vancouver

Waheed G, Mohammed HA, Ramadan G. Sodium R-lipoate protects against psoriatic skin inflammation via modulating IL-23/IL-17A axis, oxidative stress, and mast cell activation. Naunyn-Schmiedeberg's Archives of Pharmacology. 2026. doi:10.1007/s00210-026-05431-5

BibTeX
@article{Waheed2026,
  author = {Waheed, Gehan and Mohammed, Hend A and Ramadan, Gamal},
  title = {Sodium R-lipoate protects against psoriatic skin inflammation via modulating IL-23/IL-17A axis, oxidative stress, and mast cell activation},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2026},
  doi = {10.1007/s00210-026-05431-5}
}
Kostenlos starten →